Literature DB >> 17875398

Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone.

Noé Galván1, Sophia Lim, Stephan Zmugg, Martyn T Smith, Luoping Zhang.   

Abstract

Werner syndrome is a progeroid disorder caused by mutations of the WRN gene. The encoded WRN protein belongs to the family of RecQ helicases that plays a role in the maintenance of genomic stability. Single nucleotide polymorphisms in WRN have been associated with an increased risk for some cancers and were recently linked to benzene hematotoxicity. To further address the role of WRN in benzene toxicity, we employed RNA interference (RNAi) to silence endogenous WRN in HeLa cells and examined the susceptibility of these WRN-depleted cells to the toxic effects of the benzene metabolite hydroquinone. HeLa cells were used as the experimental model because RNAi is highly effective in this system producing almost complete depletion of the target protein. Depletion of WRN led to a decrease in cell proliferation and an enhanced susceptibility to hydroquinone cytotoxicity as revealed by an increase in necrosis. WRN-depleted HeLa cells treated with hydroquinone also displayed an increase in the amount of DNA double-strand breaks as determined by the Comet assay, and an elevated DNA damage response as indicated by the sevenfold induction of gammaH2AX and acetyl-p53 (Lys373 and Lys382) over control levels. Together, these results show that WRN plays an important role in the protection of HeLa cells against the toxicity of the benzene metabolite hydroquinone, specifically in mounting a normal DNA damage response following the induction of DNA double-strand breaks. Further studies in bone marrow-derived stem or progenitor cells are required to confirm our findings in HeLa cells and expand our ability to extrapolate the results to benzene toxicity in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875398      PMCID: PMC3461953          DOI: 10.1016/j.mrgentox.2007.07.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  28 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 2.  Why is p53 acetylated?

Authors:  C Prives; J L Manley
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

3.  DNA-protein crosslink and DNA strand break formation in HL-60 cells treated with trans,trans-muconaldehyde, hydroquinone and their mixtures.

Authors:  R P Amin; G Witz
Journal:  Int J Toxicol       Date:  2001 Mar-Apr       Impact factor: 2.032

4.  Redundancy of DNA helicases in p53-mediated apoptosis.

Authors:  E A Spillare; X W Wang; C von Kobbe; V A Bohr; I D Hickson; C C Harris
Journal:  Oncogene       Date:  2006-03-30       Impact factor: 9.867

5.  Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.

Authors:  Min Shen; Tongzhang Zheng; Qing Lan; Yawei Zhang; Shelia H Zahm; Sophia S Wang; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Daehee Kang; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock; Nathaniel Rothman
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

6.  Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity.

Authors:  Min Shen; Qing Lan; Luoping Zhang; Stephen Chanock; Guilan Li; Roel Vermeulen; Stephen M Rappaport; Weihong Guo; Richard B Hayes; Martha Linet; Songnian Yin; Meredith Yeager; Robert Welch; Matthew S Forrest; Nathaniel Rothman; Martyn T Smith
Journal:  Carcinogenesis       Date:  2006-05-25       Impact factor: 4.944

7.  Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.

Authors:  Michael Wirtenberger; Bernd Frank; Kari Hemminki; Rüdiger Klaes; Rita K Schmutzler; Barbara Wappenschmidt; Alfons Meindl; Marion Kiechle; Norbert Arnold; Bernhard H F Weber; Dieter Niederacher; Claus R Bartram; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2006-02-25       Impact factor: 4.944

8.  Werner protein protects nonproliferating cells from oxidative DNA damage.

Authors:  Anna M Szekely; Franziska Bleichert; Astrid Nümann; Stephen Van Komen; Elisabeth Manasanch; Abdelhakim Ben Nasr; Allon Canaan; Sherman M Weissman
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

9.  p53 Modulates the exonuclease activity of Werner syndrome protein.

Authors:  R M Brosh; P Karmakar; J A Sommers; Q Yang; X W Wang; E A Spillare; C C Harris; V A Bohr
Journal:  J Biol Chem       Date:  2001-06-26       Impact factor: 5.157

Review 10.  Roles of the Werner syndrome protein in pathways required for maintenance of genome stability.

Authors:  Robert M Brosh; Vilhelm A Bohr
Journal:  Exp Gerontol       Date:  2002-04       Impact factor: 4.032

View more
  13 in total

Review 1.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Martyn T Smith
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

Review 2.  Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.

Authors:  Hua Shen; Cliona M McHale; Martyn T Smith; Luoping Zhang
Journal:  Mutat Res Rev Mutat Res       Date:  2015-01-25       Impact factor: 5.657

3.  Emerging approaches in predictive toxicology.

Authors:  Luoping Zhang; Cliona M McHale; Nigel Greene; Ronald D Snyder; Ivan N Rich; Marilyn J Aardema; Shambhu Roy; Stefan Pfuhler; Sundaresan Venkatactahalam
Journal:  Environ Mol Mutagen       Date:  2014-07-09       Impact factor: 3.216

Review 4.  Systems biology of human benzene exposure.

Authors:  Luoping Zhang; Cliona M McHale; Nathaniel Rothman; Guilan Li; Zhiying Ji; Roel Vermeulen; Alan E Hubbard; Xuefeng Ren; Min Shen; Stephen M Rappaport; Matthew North; Christine F Skibola; Songnian Yin; Christopher Vulpe; Stephen J Chanock; Martyn T Smith; Qing Lan
Journal:  Chem Biol Interact       Date:  2009-12-21       Impact factor: 5.192

Review 5.  Application of toxicogenomic profiling to evaluate effects of benzene and formaldehyde: from yeast to human.

Authors:  Cliona M McHale; Martyn T Smith; Luoping Zhang
Journal:  Ann N Y Acad Sci       Date:  2014-02-26       Impact factor: 5.691

Review 6.  Roles of Werner syndrome protein in protection of genome integrity.

Authors:  Marie L Rossi; Avik K Ghosh; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2010-01-13

7.  Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity.

Authors:  Qing Lan; Luoping Zhang; Min Shen; William J Jo; Roel Vermeulen; Guilan Li; Christopher Vulpe; Sophia Lim; Xuefeng Ren; Stephen M Rappaport; Sonja I Berndt; Meredith Yeager; Jeff Yuenger; Richard B Hayes; Martha Linet; Songnian Yin; Stephen Chanock; Martyn T Smith; Nathaniel Rothman
Journal:  Carcinogenesis       Date:  2008-10-31       Impact factor: 4.944

8.  Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone.

Authors:  Xuefeng Ren; Sophia Lim; Martyn T Smith; Luoping Zhang
Journal:  Toxicol Sci       Date:  2008-12-08       Impact factor: 4.849

9.  Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells.

Authors:  Hua Shen; Cliona M McHale; Syed I Haider; Cham Jung; Susie Zhang; Martyn T Smith; Luoping Zhang
Journal:  Toxicol Sci       Date:  2016-03-22       Impact factor: 4.849

10.  Cellular deficiency of Werner syndrome protein or RECQ1 promotes genotoxic potential of hydroquinone and benzo[a]pyrene exposure.

Authors:  Mamatha Garige; Sudha Sharma
Journal:  Int J Toxicol       Date:  2014-09-15       Impact factor: 2.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.